Category: Business

How a Small Family Business is Becoming a Leader in the New York Cannabis Market

Meet the women of privately held, family-owned, medical marijuana company Etain Health. They’re resilient, strategic and insistent on treating each customer as one of their own. 

FOR IMMEDIATE RELEASE: Etain is currently New York’s only women-owned, family-run and vertically integrated cannabis company.

PRESS RELEASE: Hillary Peckham started Etain with her mother Amy and sister Keeley. It all began in honor of the matriarch of the family, Frances “Granny Franny” Keeffe. “

NEW YORK: During Granny Franny’s battle with amyotrophic lateral sclerosis (ALS), the three began researching medical marijuana as an alternative treatment.

The discovery of potential benefits combined with the passing of the Compassionate Care Act in 2014, initiated the launch of Etain Medical Marijuana.

The knowledge that each Etain customer is also someone’s parent, spouse, child or sibling is what gives the company its personable touch with a family-first approach and a deep focus on quality and service. 

So what’s with the namesake Etain? COO Hillary Peckham explained, “Etain is a Gallic goddess in Irish mythology. She’s the protagonist of many legends and represents women in a transformational capacity. This is the perfect way to honor my mother’s Irish heritage while giving a nod to a female-run business.”

Etain offers a little bit of everything: flower, tinctures, timed-release capsules, vapes, topicals, lozenges, and even a water-soluble powder.

With a staff size of 60 people, and operating only within the state of New York, Etain definitely falls into the small business category.

The Peckham women believe this has some benefits. “I think in some ways it’s given us the ability to be more nimble and flexible. We all have the same goals and we work really hard,” commented CEO Amy Peckham.

Etain operates its cultivation and manufacturing out of Chesterton, has dispensaries in Yonkers, Kingston, Syracuse and a flagship in Midtown East, New York City. And as one of only 10 companies in the state with a license to manufacture and distribute medical marijuana, Etain is well positioned for the inevitable growth toward federal legalization. 

Houlihan Lawrence Appoints Pamela Sartorius as Managing Director of Global Business Development

Pamela Sartorius

RYE BROOK, NY — July 29, 2021 — (PressReleaseNewsCenter.com) — Houlihan Lawrence has announced the appointment of Pamela Sartorius as its Managing Director of Global Business Development.

Sartorius will be responsible for growing the company’s referral and relocation programs through the introduction of new business opportunities, and building upon existing relationships with clients, relocation network counterparts, and the brokerage’s 1,300 agents.

Sartorius will also represent Houlihan Lawrence among the company’s local, national, and global network affiliations including Leading Real Estate Companies of the World, the largest global network in sales volume and size with over 130,000 agent connections.

Prior to joining Houlihan Lawrence, Sartorius was a Strategic Growth Manager at William Raveis Real Estate, Mortgage & Insurance (WRRE), in New York City responsible for business growth initiatives, and held senior positions at Brown Harris Stevens and Corcoran Group.

Sartorius is relocating from New York City to Westport, CT. She earned a B.A. in Communication Arts from St. Lawrence University.

About Houlihan Lawrence

Houlihan Lawrence is the leading real estate brokerage serving New York City’s northern suburbs. Founded in Bronxville, New York, in 1888, the company is deeply committed to technological innovation and the finest client service. The firm has 30 offices and 1,300+ agents serving Westchester, Putnam, Dutchess, Columbia, Ulster and Greene counties in New York and Fairfield, Litchfield Counties in Connecticut. For more information visit: http://www.houlihanlawrence.com/ | TWITTER: @HoulihanRE | INSTAGRAM: @houlihanlawrence

PRESS CONTACT:

Dean Bender

1192 Pleasantville Road, Briarcliff Manor, NY 10510

914.762.1900 ext 13

M: 914.391.6042

Magnetic Resonance Imaging (MRI) Provides Certain Advantages Compared to Computed Tomography (CT) Technology

Peter Solodko, CEO of A1 Medical Imaging

SARASOTA, Fla., June 8, 2021 (PressReleaseNewsCenter.com) – Peter Solodko, CEO of A1 Medical Imaging with Open MRI centers in Florida and Georgia, explains the advantages of magnetic resonance imaging (MRI) compared to computed tomography (CT) when it comes to obtaining detailed images of the inside of the human body.

MRI and CT scanners are based on two very different technologies.

“Computerized tomography uses computers and rotating X-ray emissions to create cross-sectional images of the internal anatomy,” Solodko said. “CT images can show the blood vessels and soft tissues. It also shows the bones throughout the body.”

Fundamentally, a CT patient lies inside a tube. The scanner rotates on the inside and takes a series of X-rays from various angles. A computer then combines the resulting images to create cross-sectional views. This minimally invasive approach provides more detail than typical X-ray images. The X-ray dose is minimal for a single scan, but the radiation can build up over time if multiple scans are required. CT scans should generally not be used on women who are pregnant.

“Magnetic resonance imaging is a non-invasive technology that uses magnets, radio waves, and computers to obtain more detailed pictures of a patient’s anatomy than CT,” Peter Solodko stated. “Also, unlike CT scans, MRI technology develops cross-sectional images that allow abnormalities in tissues and organs to be examined without bones obstructing the view.”

MRI is considered to be a safer alternative to CT scans because it does not use radiation. An MRI scanner can be used to take images of any part of the body and in any imaging direction. MRI provides better soft tissue contrast than CT and can differentiate better between fat, water, muscle, and other soft tissue than CT.

“As with a CT machine, patients typically lie down for an MRI exam, and some machine designs are a closed, confining configuration,” Solodko added. “All of our A1 Medical Imaging centers utilize an open MRI design to reduce the sense of confinement and claustrophobia.”

MRI and CT scans both require a doctor’s order, also known as a prescription or script. Without that, the procedure cannot occur. Consult with your physician to determine which of these two scanning technologies is right for you.

Please visit the A1 Medical Imaging website at www.A1mri.com to learn more about its services and locations.

About A1 Medical Imaging

A1 Medical Imaging has become a model of excellence in the medical diagnostic imaging industry. From its home office in downtown Sarasota, Florida, the company maintains primary in-house functions of administration, human resources, transcription, finance, insurance contracting, information systems and technology, billing and collections, and medical technology. Utilizing “state of the art” computer technology, A1 Medical Imaging can monitor the overall performance and operation of each center from its one central location, successfully assuring cost-effectiveness and efficiency throughout the company.

Media Contact:
Ronald G Hock
A1 Medical Imaging LLC
Email: rhock@chsmed.com

Source: A1 Medical Imaging

Rosemont Sells Minority Equity Interest in Boston Common Asset Management

Rosemont is a specialist investor exclusively focused on employee-owned asset and wealth management companies.

CONSHOHOCKEN, Pa., February 1, 2021 (PressReleaseNewsCenter.com) – Rosemont, a private investor in employee-owned asset and wealth management firms, announces the sale of Rosemont Partners III, LP’s minority equity interest in Boston Common Asset Management, LLC. Rosemont’s interest was acquired by Affiliated Managers Group, Inc. and employees of Boston Common.

Boston Common, a majority women-owned and employee-owned firm dedicated to sustainable and impact investing, was founded in 2003 by ESG pioneer Geeta Aiyer. Rosemont partnered with Boston Common in 2016, acquiring a minority stake through its third and final private equity fund. During its collaboration with Rosemont, Boston Common achieved several notable milestones, including nearly doubling its assets under management, expanding its global client base and hiring Allyson McDonald as its Chief Executive Officer.

“We have tremendous respect for the team at Boston Common and have greatly enjoyed our working relationship,” said Brad Mook, Managing Director at Rosemont. “Boston Common’s reputation and tenure as authentic ESG investors, along with its solid investment track record, position it well to continue its growth. While we would have liked to remain partners indefinitely, our legacy fund structure requires an eventual exit and is a key reason we have since transitioned our investment model to permanent capital. We wish Boston Common and AMG well in their new partnership.”

Ally McDonald, CEO at Boston Common, said, “Rosemont has been an invaluable partner to our firm since its investment in 2016. Rosemont’s industry knowledge, robust network and sounding board approach have been consistently helpful in many areas of our business, and we appreciate its support over the past several years.”

Terms of the transaction were not disclosed.

About Rosemont

Rosemont is a specialist investor exclusively focused on a select number of partnerships with high-quality, employee-owned asset and wealth management companies. Rosemont acquires minority equity positions in support of management buyouts, recapitalizations, ownership transitions, and selected start-ups. In addition to its experience providing capital and employee-driven ownership solutions, Rosemont partners leverage its deep network and knowledge of the investment management industry developed through more than 30 years of advising and investing in asset and wealth management businesses. For more information visit www.rosemontinv.com.

About Boston Common

Boston Common is a boutique global equity investment firm and a leader in global impact initiatives dedicated to the pursuit of financial return and social change. Boston Common was founded in 2003 and is majority women-owned and employee-owned. The company manages active, long-only ESG strategies in U.S., non-U.S. and global equities and had $3.9 billion in assets under management as of December 31, 2020. For more information visit www.bostoncommonasset.com.

Press Contacts:

Brad Mook, Managing Director

Ally McDonald, Chief Executive Officer

Rosemont

Boston Common

(610) 260-2621

(617) 960-3895

bmook@rosemontinv.com

amcdonald@bostoncommonasset.com

Source: Rosemont